Search results for "Therapeutic agents"

showing 8 items of 8 documents

Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine

2016

collaboration au projet H2020 European Cooperation in Science and Technology (COST) program European Network on Microvesicles and Exosomes in Health and Disease (ME-HAD); International audience; Recent research has demonstrated that all body fluids assessed contain substantial amounts of vesicles that range in size from 30 to 1000 nm and that are surrounded by phospholipid membranes containing different membrane microdomains such as lipid rafts and caveolae. The most prominent representatives of these so-called extracellular vesicles (EVs) are nanosized exosomes (70-150 nm), which are derivatives of the endosomal system, and microvesicles (100-1000 nm), which are produced by outward budding…

0301 basic medicineMedical nanotechnologyPhysiologyMedizinGeneral Physics and Astronomyxxx xxxCell CommunicationExosomesRegenerative medicineTheranostic NanomedicineMembrane microparticleEngineering (all)Drug Delivery SystemsPathophysiologicalCell-Derived MicroparticlesCaveolaeDiagnosisGeneral Materials ScienceLipid raftPhospholipidsClinical Trials as TopicPhospholipid membraneVesicleGeneral EngineeringScience and TechnologyEngineering (all); Materials Science (all); Physics and Astronomy (all)3. Good healthCell biologyIntercellular communicationsClinical trial (topic)NanomedicineDrug deliveryRegenerative medicine[SDV.IMM]Life Sciences [q-bio]/ImmunologyNanomedicineMaterials Science (all)HumanEndosomeDrug delivery systemNanotechnologyBiologyProgram diagnosticsPhysics and Astronomy (all)03 medical and health sciencesExtracellular VesiclesAnimalsHumansTherapeutic agentsSettore BIO/16 - Anatomia UmanaAnimalRecent researchesMicrovesiclesCell membranesExosome030104 developmental biologyInternational cooperationMembrane microdomains
researchProduct

Natural payload delivery of the doxorubicin anticancer drug from boron nitride oxide nanosheets

2019

International audience; We studied the behavior of doxorubicin (DOX; an anticancer drug) molecules loaded on a boron nitride oxide nanosheet (BNO-NS) using the density functional theory (DFT), time-dependent density functional theory (TDDFT), and molecular dynamic (MD) simulation methods. We found that DOX molecules in pi-pi or covalent interaction with BNO-NS preserve their optical properties in water. Moreover, the BNO-NS vector allowed stabilizing the DOX molecules on a cellular membrane contrary to isolated DOX that randomly moved in the solvent box without any interaction with the cell membrane. From these results, we conclude that hydrophilic BNO-NS represents a good candidate for DOX…

General Physics and Astronomy02 engineering and technologyMolecular dynamics010402 general chemistry01 natural sciences[SPI.MAT]Engineering Sciences [physics]/MaterialsCell membranechemistry.chemical_compoundmedicinepolycyclic compoundsTime-dependent density functional theoryMolecule[CHIM]Chemical SciencesDoxorubicin[SPI.NANO]Engineering Sciences [physics]/Micro and nanotechnologies/MicroelectronicsBoron nitride oxide nanosheetsNanosheet[SPI.ACOU]Engineering Sciences [physics]/Acoustics [physics.class-ph]Therapeutic agentsChemistrytechnology industry and agricultureSurfaces and InterfacesGeneral ChemistryTime-dependent density functional theory021001 nanoscience & nanotechnologyCondensed Matter Physics0104 chemical sciencesSurfaces Coatings and FilmsSolventmedicine.anatomical_structureBoron nitrideDrug deliveryBiophysics0210 nano-technologymedicine.drug
researchProduct

THIOPYRANO[2,3-E]INDOL-2-ONES: ANGELICIN HETEROANALOGUES WITH POTENT PHOTOANTIPROLIFERATIVE ACTIVITY

2008

A new class of compounds, the thiopyrano[2,3-e]indol-2-ones, bioisosters of the angular furocoumarin angelicin, was synthesized with the aim of obtaining new photochemotherapeutic agents. In particular 7,8-dimethyl-thiopyranoindolone 6c s showed a remarkable phototoxicity and a great dose UVA dependence reaching IC(50) values at submicromolar level. This latter photoinduced a massive apoptosis and a remarkable photodamage to lipids and proteins. Although it did not intercalate DNA, it was able to cause photooxidation of DNA bases.

IndolesStereochemistryDNA damageUltraviolet RaysAngelicinThiopyrano[23-e ]indol-2-oneClinical BiochemistryPharmaceutical ScienceHL-60 CellsApoptosisThiopyrano[2Antiproliferative activityBiochemistryChemical synthesischemistry.chemical_compoundInhibitory Concentration 50Jurkat CellsAngelicinPhotochemotherapeutic agentsFurocoumarinsDrug DiscoveryThiolactoneTumor Cells CulturedHumansPhotosensitizer3-e ]indol-2-onesMolecular BiologyPhotosensitizing AgentsFurocoumarinOrganic ChemistryProteinsBiological activityThiopyrano[2; 3-e ]indol-2-ones; Angelicin; Antiproliferative activity; Photochemotherapeutic agents; ApoptosisDNASettore CHIM/08 - Chimica FarmaceuticaMitochondriachemistryPhotochemotherapeutic agentMolecular MedicineLipid PeroxidationPhototoxicityDNA Damage
researchProduct

PHOTOCHEMOTHERAPEUTIC AGENTS: DESIGN, SYNTHESIS AND ANTITUMOR ACTIVITY

2009

PHOTOCHEMOTHERAPEUTIC AGENTS
researchProduct

Pyrrolo[3,2-h]quinazolines as Photochemotherapeutic Agents

2011

Heteroanalogues of angelicin, pyrrolo[3,2-h]quinazolines, were synthesized with the aim of obtaining new potent photochemotherapeutic agents. Many derivatives caused a significant decrease in cell proliferation in several human tumor cell lines after irradiation with UVA light (GI(50) =15.2-0.2 μM). Their phototoxicity effected apoptosis in Jurkat cells with the involvement of mitochondria (as determined by the loss of mitochondrial membrane potential and production of reactive oxygen species) and lysosomes. The phototoxicity of these compounds could be explained by lipid peroxidation.

Pyrrolo[3; 2-h]quinazolines; Angelicin; Photochemotherapeutic AgentsAngelicinUltraviolet RaysApoptosisMitochondrion2-h]quinazolinesBiochemistryJurkat cellsLipid peroxidationStructure-Activity Relationshipchemistry.chemical_compoundAngelicinCell Line TumorFurocoumarinsPhotochemotherapeutic AgentsDrug DiscoveryHumansPyrrolo[32-h]quinazolinePyrrolesPyrrolo[3General Pharmacology Toxicology and PharmaceuticsPharmacologychemistry.chemical_classificationReactive oxygen speciesPhotosensitizing AgentsOrganic ChemistrySettore CHIM/08 - Chimica FarmaceuticachemistryBiochemistryApoptosisCell cultureQuinolinesMolecular MedicineDrug Screening Assays AntitumorReactive Oxygen SpeciesPhototoxicityChemMedChem
researchProduct

Pyrrolo[3,4-h]quinolinones a new class of photochemotherapeutic agents

2011

Abstract Pyrrolo[3,4- h ]quinolin-2-ones were synthesized as nitrogen isosters of the angular furocoumarin angelicin, with the aim of obtaining new photochemotherapeutic agents with increased antiproliferative activity and lower undesired toxic effects. A versatile synthetic pathway was approached to allow the isolation of derivatives of the new ring system with a good substitution pattern on the pyrrole moiety. Photobiological screenings of the new compounds revealed a potent phototoxic effect and a great UVA dose dependence, reaching IC 50 values at submicromolar level. The induced cellular photocytotoxicity was related to apoptosis with the involvement of mitochondria and lysosomes, alte…

Pyrrolo[3; 4-h]quinolinones; Angelicin heteroanalogues; Photochemotherapeutic agents; PhototoxicityStereochemistryClinical BiochemistryMembrane lipid peroxidationPharmaceutical ScienceHL-60 CellsPhosphatidylserinesQuinolonesMitochondrionBiochemistryPhototoxicityJurkat CellsStructure-Activity Relationshipchemistry.chemical_compoundPhotochemotherapeutic agentsAngelicinCell Line TumorDrug DiscoveryHumansMoietyFluorometryPyrrolesPyrrolo[3Molecular BiologyPyrrolePyrrolo[34-h]quinolinoneFurocoumarinCell CycleOrganic Chemistry4-h]quinolinonesDNAPhotochemical ProcessesSettore CHIM/08 - Chimica FarmaceuticaAngelicin heteroanaloguesPhotochemotherapeutic agentPhotochemotherapychemistryApoptosisMolecular MedicineLipid PeroxidationPhototoxicityAngelicin heteroanalogueSubcellular FractionsBioorganic & Medicinal Chemistry
researchProduct

Endothelial Progenitor Cells A New Real Hope?

2017

Chronic inflammatory diseases, such as cardiovascular diseases (CVDs), diabetes, Alzheimer’s disease (AD) and cancer, have a disproportionate prevalence with advancing age owing to the continuous growth in the aging population. This condition determines several medical, economic and social problems due to the dramatic increase in the number of affected individuals, who are not autonomous. Thus, research efforts are centred around reducing and/or delaying the onset and progression of these diseases by researching new strategies for early prevention and diagnosis. In this context, understanding the mechanisms involved in the tissue, organ protection and repair are imperative for the developme…

Settore MED/05 - Patologia ClinicaEndothelial progenitor cells biomarkers therapeutic agents age-related diseases
researchProduct

Role of Chemerin in Cardiovascular Diseases.

2022

(1) Background: Obesity is closely connected to the pathophysiology of cardiovascular diseases (CVDs). Excess fat accumulation is associated with metabolic malfunctions that disrupt cardiovascular homeostasis by activating inflammatory processes that recruit immune cells to the site of injury and reduce nitric oxide levels, resulting in increased blood pressure, endothelial cell migration, proliferation, and apoptosis. Adipose tissue produces adipokines, such as chemerin, that may alter immune responses, lipid metabolism, vascular homeostasis, and angiogenesis. (2) Methods: We performed PubMed and MEDLINE searches for articles with English abstracts published between 1997 (when the first re…

adipokinechemerin receptorsMedicine (miscellaneous)610 Medicine & health2701 Medicine (miscellaneous)endothelial dysfunctionGeneral Biochemistry Genetics and Molecular Biologyadipokine cardiovascular disease chemerin chemerin receptors chemerin-targeting therapeutic agents endothelial dysfunction inflammation1300 General Biochemistry Genetics and Molecular Biologycardiovascular diseaseinflammation10209 Clinic for Cardiologychemerin-targeting therapeutic agentschemerinBiomedicines
researchProduct